CytomX Therapeutics
A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
2
Funding Rounds
$71.0m
Money raised
Overview
A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
-
Website:
- Business model: B2B
- Headquarters: San Francisco
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa Da** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Se** Mc* | - | - | - |
| Al** As* | - | - | - |
| El**** Jo*** | - | - | |
| Ha**** Gi | - | - | |
| Ja*** R. Me**** | - | - | |
| Ma** Mo* |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Se** Mc* | - | - | - |
Funding series
Funding Series Analysis
The company CytomX Therapeutics has raised a total of $30m in funding over 2 rounds.
Key Insights:
- CytomX Therapeutics Series B round: $30m
- CytomX Therapeutics Series B round August 2012: $41m
CytomX Therapeutics Series B round
$30m
CytomX Therapeutics Series B round August 2012
$41m
Industries
CytomX Therapeutics is active in the following industries: